[Skip to Navigation]
Comment & Response
April 2018

Uses of H.P. Acthar Gel in the Clinical Setting

Author Affiliations
  • 1Mallinckrodt Pharmaceuticals, Bedminster, New Jersey
JAMA Intern Med. 2018;178(4):583. doi:10.1001/jamainternmed.2017.8542

To the Editor We read with interest a Research Letter published in a recent issue of JAMA Internal Medicine by Hartung et al.1 Mallinckrodt, manufacturer of repository corticotropin injection (H.P. Acthar Gel [Acthar]), is dedicated to providing appropriate treatment options for patients with inflammatory and autoimmune diseases, and we would like to share our view on Acthar.2

Add or change institution